Таблетки Nextnib 50 мг

What is Nextnib 50 mg Tablets?
Nextnib 50 mg is a prescription medication containing the active ingredient Nintedanib. It is used in the treatment of certain types of lung cancer and idiopathic pulmonary fibrosis (IPF).

How it Works:
Nintedanib is a tyrosine kinase inhibitor. It works by blocking the activity of certain enzymes that are involved in the growth and spread of cancer cells and in the scarring process of lung tissue in IPF. By inhibiting these enzymes, Nintedanib helps to slow down the progression of the disease.

Indications:
Nextnib 50 mg is indicated for:
* Idiopathic Pulmonary Fibrosis (IPF): To slow the rate of lung function decline.
* Certain types of Non-Small Cell Lung Cancer (NSCLC): In combination with docetaxel, for patients who have received prior chemotherapy.

Dosage and Administration:
The usual starting dose of Nextnib 50 mg is one capsule twice daily. It is important to take this medication exactly as prescribed by your doctor. The dosage may be adjusted based on your individual response and tolerance. It is typically taken with food.

Side Effects:
Common side effects may include diarrhea, nausea, vomiting, abdominal pain, decreased appetite, fatigue, and elevated liver enzymes. Serious side effects can occur, so it is crucial to discuss any concerns with your healthcare provider.

Storage:
Store Nextnib 50 mg tablets at room temperature, away from moisture and heat. Keep out of reach of children.